| 26/05 | Europe : bourses apathiques avant l'inflation US |  |
| 26/05 | Novo Nordisk : avis positif du CHMP pour Sogroya | |
| 26/05 | Novo Nordisk's Growth Hormone Therapy Wins EU Health Agency Backing for Use in Children.. |  |
| 26/05 | Engpass bei Novo-Nordisk-Diabetesmittel durch Off-Label-Nutzung als Abnehmhilfe |  |
| 24/05 | Novo Nordisk, Life Edit Therapeutics Collaborate to Discover Gene Editing Therapies for.. | |
| 24/05 | Novo Nordisk Teams Up with ElevateBio Unit to Develop Gene Editing Therapies | |
| 24/05 | Novo Nordisk : accord de R&D avec Life Edit Therapeutics | |
| 24/05 | Novo Nordisk, Life Edit Therapeutics in Gene-Editing Collaboration | |
| 24/05 | Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discove.. | |
| 24/05 | Novo Nordisk : Stifel maintient sa note sur le titre | |
| 24/05 | Eli-Lilly-Chef hofft auf Kassenschlager bei neuen Medikamenten | |
| 24/05 | ElevateBio, LLC announced that it has received $401 million in funding from a group of .. | |
| 23/05 | Global markets live: Micron, Qantas, Zoom, Meta, BT Group... | |
| 23/05 | Pathos Obtains Worldwide Rights From Novo Nordisk for the Development of CBP/p300 Inhib.. | |
| 23/05 | Novo Nordisk A/S, Oral semaglutide 50 mg achieved 15.1% weight loss in adults with obes.. | |
| 23/05 | Novo Nordisk : Oddo BHF maintient sa recommandation | |
| 23/05 | Novo Nordisk : résultats prometteurs pour le semaglitude | |
| 23/05 | EN DIRECTO DESDE LOS MERCADOS: JPMorgan, Inditex, Micron, .. |  |
| 23/05 | Bolsa de Madrid: Los plumíferos se mueven | |
| 23/05 | Les emplafonnés s'activent | |
| 23/05 | En Direct des Marchés : Société Générale, Faurecia, Casino, Bondue.. | |
| 23/05 | Weight-loss drug pioneers aim to jump on Wegovy bandwagon | |
| 22/05 | Health Care Up Slightly as Pfizer Rallies on Weight-Drug Hopes -- Health Care Roundup | |
| 22/05 | Novo Nordisk Says Phase 3a Trial of Once-Daily Oral Semaglutide 50 Milligram Meets Prim.. | |
| 22/05 | Equity Markets Struggle for Direction With Debt Ceiling Discussions in Focus | |
| 22/05 | Wall Street ends mixed as investors await debt ceiling talks | |
| 22/05 | Equity Markets Struggle for Direction With Debt Ceiling Discussions in Focus | |
| 22/05 | Las pastillas para adelgazar de Novo y Pfizer funcionan tan bien como la inyección | |
| 22/05 | Aktien New York Schluss: Kaum verändert vor Schuldenstreit-Gespr.. | |
| 22/05 | Sector Update: Health Care Stocks Slightly Higher Late Monday | |
| 22/05 | Sector Update: Health Care Stocks Advancing Monday Afternoon | |
| 22/05 | Aktien New York: Dow schwächelt leicht - Warten auf Lösung im Schuldenst.. | |
| 22/05 | Sector Update: Health Care | |
| 22/05 | Les actions freinées par la prudence sur la dette américaine | |
| 22/05 | Aktien Europa Schluss: Wenig verändert - Rally an Griechenlands Bö.. | |
| 22/05 | Point marchés-Les actions freinées par la prudence sur la dette américaine | |
| 22/05 | Novo Nordisk says trial of oral weight-loss drug shows significant result | |
| 22/05 | Top Stories at Midday: Meta Hit With $1.3 Billion Fine; China Bans.. | |
| 22/05 | Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic | |
| 22/05 | Pfizer Shares Rise After Trial Reportedly Shows Danuglipron Causes as Much Weight Loss .. | |
| 22/05 | Shares of pfizer inc up 4.4% after diabetes drug resulted in wei… | |
| 22/05 | Pfizer diabetes drug reduces weight similar to Novo's Ozempic | |
| 22/05 | Pfizer's Weight Loss Drug Danuglipron Seen as Effective as Novo Nordisk's Ozempic; Pfiz.. | |
| 22/05 | Novo Nordisk Reports Statistically Significant Results from Phase 3a Trial of Weight Ma.. | |
| 22/05 | Novo Nordisk A/s: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people .. | |
| 22/05 | Novo Nordisk A/S Announces Headline Results from OASIS 1 | |
| 22/05 | Intercept tumbles on concerns over prospects of fatty liver disease drug | |
| 22/05 | Novo Nordisk A/S - share repurchase programme | |
| 22/05 | Les actions sur la défensive avant des discussions sur la dette américaine | |
| 22/05 | Intercept shares tumble on concerns over NASH drug prospects | |
| 22/05 | Point marchés-Les actions sur la défensive avant des discussions sur la dette américain.. | |
| 22/05 | Aktien Europa: Träger Wochenstart | |
| 22/05 | European stocks muted as US debt ceiling concerns linger | |
| 22/05 | La preocupación por el techo de deuda de EEUU hace mella en las bolsas europeas | |
| 22/05 | European stocks muted as US debt ceiling concerns weigh | |
| 22/05 | Nanexa - Moments of truth closing in | |
| 22/05 | Les valeurs à suivre à Paris et en Europe (actualisé) | |
| 20/05 | Obesity drug brings heart health benefit alongside weight loss - study | |
| 19/05 | US FDA panel votes against approval of Intercept fatty liver drug, cites safety issues | |
| 19/05 | Catalent cuts annual revenue forecast hurt by operational challenges | |
| 19/05 | Novo Nordisk : Taking on board another upbeat performance | |
| 17/05 | Novo Holdings leads $100M Series a Financing to Advance Gene Therapies for Blinding Dis.. | |
| 15/05 | Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa.. | |
| 15/05 | Novo Nordisk A/S - share repurchase programme | |
| 12/05 | Sector Update: Health Care Stocks Easing Late Friday | |
| 12/05 | Sector Update: Health Care Stocks Dropping in Afternoon Trading | |
| 12/05 | Sector Update: Health Care | |
| 12/05 | Novo Nordisk, Eli Lilly's Weight-Loss Drugs Not a 'Silver Bullet' for Obesity, WHO Repo.. | |
| 12/05 | Weight-loss drugs: the next gold rush | |
| 12/05 | Exclusive-Wegovy, other weight loss drugs 'no silver bullet', says WHO amid obesity rev.. | |
| 10/05 | Insulin makers testify on Capitol Hill over prices | |
| 10/05 | Sen. Sanders grills Pharma CEOs on insulin prices | |
| 10/05 | Sen. Sanders grills Pharma CEOs on insulin prices | |
| 10/05 | Pharma CEOs to testify in U.S. Senate hearing on insulin prices | |
| 10/05 | Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa.. | |
| 10/05 | Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial | |
| 09/05 | Trading in Novo Nordisk shares by board members, executives and associated persons | |
| 09/05 | Novo Nordisk A/S - share repurchase programme | |
| 09/05 | Novo Nordisk A/S purchases B shares worth DKK 3,889 million from Novo Holdings A/S unde.. | |
| 09/05 | Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa.. | |
| 09/05 | Komodo Health Platform Powers 17 Cutting-Edge Health Economics and Outcomes Research Pr.. | |
| 09/05 | Los mercados bursátiles escandinavos: especificidad.. | |
| 08/05 | Aktien Europa Schluss: Moderate Gewinne zu Wochenbeginn | |
| 08/05 | Les marchés boursiers scandinaves : spécificités, opér.. | |
| 08/05 | Catalent shares tank on warning of $400 mln cut to annual revenue forecast | |
| 08/05 | Les actions en mouvement : Nanobiotix on fire, Samhällsbyggnads.. | |
| 08/05 | After weight loss, Alzheimer's may be next frontier for drugs like Ozempic | |
| 08/05 | Aktien Europa: Stabiler Wochenstart - Ölwerte gefragt | |
| 08/05 | Las bolsas europeas abren sin cambios a la espera de los datos de inflación de EEUU | |
| 08/05 | European shares muted ahead of key U.S. inflation data | |
| 05/05 | Novo Nordisk : dépassé par la demande pour son anti-obésité | |
| 05/05 | ANALYSEN DES TAGES von Dow Jones Newswires (05.05.2023) | |
| 05/05 | Adipositas als Hoffnungsträger der Pharmabranche | |
| 05/05 | La interrupción del suministro de Wegovy de Novo Nordisk, en el punto de mira -- Market.. | |
| 05/05 | Equity Research | Nanexa: Solid progress in development into 2023, with funding needs on .. | |
| 04/05 | Novo Nordisk rivals see room to compete in $100 bln weight-loss drug market | |
| 04/05 | Global markets live: Adecco, Qualcomm, Shell, Vodafone, Unilever... | |
| 04/05 | Aktien Europa Schluss: Kurse fallen nach weiterer Zinserhöhung | |
| 04/05 | CAC40 : la lourdeur l'emporte,la BCE veut freiner l'inflation | |
| 04/05 | Novo Nordisk : Good Q1, but markets have too high expectations | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
